Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients
Conditions: Pulmonary Aspergillosis - Invasive; Acute Myeloid Leukemia Interventions: Drug: F901318; Drug: Caspofungin Sponsors: F2G Ltd.; University Hospital of Cologne Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2016 Category: Research Source Type: clinical trials
STRIVE: CD101 Compared to Caspofungin Followed by Oral Step Down Treatment in Subjects With Candidemia
Conditions: Candidemia; Mycoses; Fungal Infection; FungemiaInterventions: Drug: CD101 Injection; Drug: Caspofungin; Drug: Fluconazole; Other: intravenous placebo; Other: oral placeboSponsor: Cidara Therapeutics Inc.Not yet recruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2016 Category: Research Source Type: clinical trials